Medigus Ltd. logo
Medigus Ltd. MDGS
report update icon

Annual report 2024
added 04-25-2026

Medigus Ltd. Financial Ratios 2024-2011 | MDGS

Annual Financial Ratios Medigus Ltd.

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

- - - - - -9.5 -15.6 -299.4 -73.6 -304.4 - - - -

P/S

- - - - - 495.1 235.9 1636.3 1203.0 4663.8 - - - -

EPS

- - - 0.0 -0.0 -0.2 -0.2 -0.2 -2.6 -0.3 - - - -

EV (Enterprise Value)

11.2 M 22.1 M 22.9 M -15.7 M -22.4 M 133 M 95.4 M 763 M 659 M 2.88 B - - - -

EBITDA per Share

- - - - - -0.181 -0.157 -0.0203 -0.261 -0.331 - - - -

EV/EBITDA

- - - - - -9.1 -14.0 -298.3 -73.2 -302.3 - - - -

PEG

- - - - - 113.21 99.82 5721.32 384.61 1314.89 - - - -

P/B

- - - - - - 12.7 - - 283.6 - - - -

P/CF

- - - - - -49.0 -24.3 -163.2 -71.0 -105.8 - - - -

ROE %

- - - 15.45 - - -81.42 - - -93.15 - - - -

ROA %

- - - 6.77 - -106.34 -58.53 -35.40 -190.07 -20.02 - - - -

ROCE %

- - - -37.78 -28.19 -106.94 -59.53 - - - - - - -

Current Ratio

1.9 2.0 2.3 7.2 - 106.1 56.5 - - - - - - -

DSO

- - - - - 29.4 20.1 - - - - - - -

DIO

- - - - - - - - 410.6 1575.5 - - - -

Operating Cycle

- - - - - - - - 410.6 1575.5 - - - -

Cash Conversion Cycle

- - - - - - - - 410.6 1575.5 - - - -

All numbers in USD currency

Quarterly Financial Ratios Medigus Ltd.

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

- - - - - - - - - - - - - - - - - - -0.06 - - - 0.06 - - - - - - - - - - - - - - - - - - - - - - - - -

ROE %

- - - - - - - - - - - - - - -34.21 -68.41 -68.41 -34.21 -19.97 28.48 28.48 14.24 14.24 - - - - - - - - - - - - - - - - - - - - - - - - -

ROA %

- - - - - - - - - - - - - - -23.93 -47.87 -47.87 -23.93 -23.93 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

ROCE %

- - - - - - - - - - - - - - -27.50 -55.00 -55.00 -27.50 -51.86 -48.72 -48.72 -24.36 -24.36 - - - - - - - - - - - - - - - - - - - - - - - - -

Current Ratio

- - - - 7.2 - 6.6 - 5.3 - 4.0 - 2.6 - 3.0 - 3.6 - 3.3 - 4.2 - - - 2.6 - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Multiples are an important financial analysis tool for the company Medigus Ltd., allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.

Advantages of Using Financial Ratios
  • Simplified Data Analysis
    Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition.
  • Comparability Between Companies
    Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations.
  • Identification of Trends and Issues
    Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks.
  • Decision Support
    Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions.
  • Accelerated Assessment of Investment Attractiveness
    Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.

Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.

Financial Ratios of other stocks in the Medical devices industry

Issuer Price % 24h Market Cap Country
Titan Medical Titan Medical
TMDI
- -26.32 % $ 19.6 M canadaCanada
Natus Medical Incorporated Natus Medical Incorporated
NTUS
- 1.94 % $ 1.05 B usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
- 0.15 % $ 844 M usaUSA
Inari Medical Inari Medical
NARI
- - $ 4.23 B usaUSA
Invacare Corporation Invacare Corporation
IVC
- - $ 24.7 M usaUSA
NuVasive NuVasive
NUVA
- - $ 2.07 B usaUSA
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
- - $ 3.31 B usaUSA
ThermoGenesis Holdings ThermoGenesis Holdings
THMO
- -25.84 % $ 171 K usaUSA
Talis Biomedical Corporation Talis Biomedical Corporation
TLIS
- 3.55 % $ 7.96 M usaUSA
Viveve Medical Viveve Medical
VIVE
- -15.35 % $ 1.71 M usaUSA
ViewRay ViewRay
VRAY
- 1.54 % $ 468 M usaUSA
SmileDirectClub SmileDirectClub
SDC
- -53.45 % $ 9.71 M usaUSA
Acutus Medical Acutus Medical
AFIB
- -26.83 % $ 2.62 M usaUSA
BIOLASE BIOLASE
BIOL
- -13.19 % $ 166 K usaUSA
Vapotherm Vapotherm
VAPO
- 6.72 % $ 34 M usaUSA
SeaSpine Holdings Corporation SeaSpine Holdings Corporation
SPNE
- 0.28 % $ 270 M usaUSA
Nevro Corp. Nevro Corp.
NVRO
- - $ 217 M usaUSA
Abiomed Abiomed
ABMD
- - $ 17.2 B usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
- 3.58 % $ 2.21 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
- - $ 475 M usaUSA
Avinger Avinger
AVGR
- -20.74 % $ 369 K usaUSA
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
- - $ 1.77 B usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
- 24.59 % $ 44.8 M chinaChina
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
- -5.86 % $ 30.6 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
- -1.98 % $ 98.3 M usaUSA
EDAP TMS S.A. EDAP TMS S.A.
EDAP
- - $ 162 M franceFrance
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
- 1.15 % $ 34.5 M usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
- -1.42 % $ 435 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
- 0.03 % $ 1.58 B israelIsrael
Misonix, Inc. Misonix, Inc.
MSON
- - $ 462 M usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
- - $ 955 M usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
- -4.14 % $ 702 M usaUSA
Avanos Medical Avanos Medical
AVNS
$ 24.99 - $ 1.16 B usaUSA
Aziyo Biologics Aziyo Biologics
AZYO
- 1.37 % $ 20.5 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
- 37.08 % $ 85.7 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
- 14.99 % $ 929 K usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
- -0.97 % $ 54.4 M usaUSA
FONAR Corporation FONAR Corporation
FONR
- - $ 140 M usaUSA
GBS GBS
GBS
- -0.57 % $ 7.12 M usaUSA
NanoVibronix NanoVibronix
NAOV
- - $ 1.08 M usaUSA
Ra Medical Systems Ra Medical Systems
RMED
- 10.0 % $ 610 K usaUSA
ReWalk Robotics Ltd. ReWalk Robotics Ltd.
RWLK
- 7.07 % $ 66.1 M israelIsrael
STRATA Skin Sciences STRATA Skin Sciences
SSKN
- - $ 6.6 M usaUSA
LivaNova PLC LivaNova PLC
LIVN
$ 76.5 0.76 % $ 4.17 B britainBritain
Outset Medical Outset Medical
OM
$ 3.0 0.66 % $ 45.6 K usaUSA
Abbott Laboratories Abbott Laboratories
ABT
$ 98.83 0.03 % $ 172 B usaUSA
Aethlon Medical Aethlon Medical
AEMD
$ 6.52 2.19 % $ 4.39 M usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
$ 5.64 0.09 % $ 762 M usaUSA
Align Technology Align Technology
ALGN
$ 145.35 0.93 % $ 10.5 B usaUSA
Apyx Medical Corporation Apyx Medical Corporation
APYX
$ 2.45 4.0 % $ 101 M usaUSA